Does TENOFOVIR DISOPROXIL Cause Focal segmental glomerulosclerosis? 12 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Focal segmental glomerulosclerosis have been filed in association with TENOFOVIR DISOPROXIL (Tenofovir Disoproxil Fumarate). This represents 0.0% of all adverse event reports for TENOFOVIR DISOPROXIL.
12
Reports of Focal segmental glomerulosclerosis with TENOFOVIR DISOPROXIL
0.0%
of all TENOFOVIR DISOPROXIL reports
0
Deaths
1
Hospitalizations
How Dangerous Is Focal segmental glomerulosclerosis From TENOFOVIR DISOPROXIL?
Of the 12 reports, 1 (8.3%) required hospitalization.
Is Focal segmental glomerulosclerosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TENOFOVIR DISOPROXIL. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does TENOFOVIR DISOPROXIL Cause?
Bone density decreased (10,586)
Renal injury (9,255)
Skeletal injury (8,320)
Chronic kidney disease (7,230)
Osteonecrosis (7,182)
Bone loss (7,040)
Multiple fractures (6,793)
Renal failure (6,388)
Osteoporosis (5,302)
Tooth loss (4,483)
What Other Drugs Cause Focal segmental glomerulosclerosis?
TACROLIMUS (339)
MYCOPHENOLATE MOFETIL (181)
PREDNISONE (173)
CYCLOSPORINE (96)
METHYLPREDNISOLONE (81)
PREDNISOLONE (73)
RITUXIMAB (73)
BASILIXIMAB (67)
OMEPRAZOLE (60)
LANSOPRAZOLE (55)
Which TENOFOVIR DISOPROXIL Alternatives Have Lower Focal segmental glomerulosclerosis Risk?
TENOFOVIR DISOPROXIL vs TEPLIZUMAB-MZWV
TENOFOVIR DISOPROXIL vs TEPOTINIB
TENOFOVIR DISOPROXIL vs TEPROTUMUMAB
TENOFOVIR DISOPROXIL vs TEPROTUMUMAB-TRBW
TENOFOVIR DISOPROXIL vs TERAZOSIN